A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports
From Health Newsfeed – Johns Hopkins Medicine Podcasts by Johns Hopkins Medicine
June 11, 2026 · 1 min
About this episode
The episode discusses a new drug, Daraxonrasib, that significantly improves survival rates for pancreas cancer patients.
Daraxonrasib is the name of a drug for pancreas cancer that almost doubled survival for people with the disease in a clinical trial. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says while the drug is going … A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports Read More »
People in this episode
Host: Elizabeth Tracey
Topics covered
- pancreas cancer
- drug development
- clinical trials
- survival rates
- cancer treatment
Keywords
- Daraxonrasib
- pancreas cancer
- survival
- clinical trial
- Kimmel Cancer Center
Mentioned in this episode
Organizations: Kimmel Cancer Center
Products: Daraxonrasib
Places: Johns Hopkins
More episodes of Health Newsfeed – Johns Hopkins Medicine Podcasts
- An AI model may help predict who is more likely to develop pancreas cancer, Elizabeth Tracey reports · June 11, 2026 · 1 min
- Will GLP1 drugs tease out the relationship between insulin and cancer? Elizabeth Tracey reports · June 11, 2026 · 1 min
- Is there a relationship between diet, obesity and colorectal cancer? Elizabeth Tracey reports · June 11, 2026 · 1 min
- What accounts for increases in colorectal cancer among younger people? Elizabeth Tracey reports · June 11, 2026 · 1 min
- A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports · June 8, 2026 · 1 min
- Certain groups of people seem to be missing out when it comes to optimizing cardiovascular disease prevention, Elizabeth Tracey reports · June 8, 2026 · 1 min
Explore listener stats, chart rankings, contacts and more on the Health Newsfeed – Johns Hopkins Medicine Podcasts podcast page.